Curanex Pharmaceuticals

CURXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$6.900 M

$4.40 -4.35%

Close of 18 Sept 2026

Revenue

—

Not reported

Earnings

-$4.23M

Loss-making

Shares outstanding

31,364,812

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#448CNS PharmaceuticalsCNSP$7.47M
#449Enveric BiosciencesENVB$7.25M
#450Curanex PharmaceuticalsCURX$6.90M
#451Bolt BiotherapeuticsBOLT$6.86M
#452Lexaria BioscienceLEXX$6.83M

What if Curanex Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $30.4T

$19,376,780

Per share 4,403,814× higher

Bitcoin $1.64T

$1,043,225

Per share 237,097× higher

Nvidia $5.36T

$3,415,742

Per share 776,305× higher

Or at a round number

$10.0M $20.0M $50.0M $100.0M

Where these numbers come from

Share counts and financials for Curanex Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 19 Sept 2026. Read the methodology.